| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/19/2005 | US20050106730 Compositions and methods utilizing stable reporter cell lines for detection of pathway-specific signal transduction |
| 05/19/2005 | US20050106727 Peptides for enhanced cell attachment and growth |
| 05/19/2005 | US20050106725 Method of reducing cell differentiation |
| 05/19/2005 | US20050106724 Self renewing dental follicle tissues for use in generating periodontal ligament like membrane structures; tissue repair and regenerative medicine |
| 05/19/2005 | US20050106723 Using matrix immobilized intergrin receptors as adhesion tools in isolation and enrichment of keratinocyte progenitor cells; treating skin disorders |
| 05/19/2005 | US20050106721 Cell immobilization material characterized by presence of hydrophobic and hydrophilic chains for use in generation of matrix comprised of conjugated cells and phospholipid vesicle; drug screening and genomic analysis |
| 05/19/2005 | US20050106720 Device and method for cultivating tissue cells |
| 05/19/2005 | US20050106695 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 05/19/2005 | US20050106682 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
| 05/19/2005 | US20050106680 Interferon-like protein Zcyto21 |
| 05/19/2005 | US20050106679 Leptin proteins |
| 05/19/2005 | US20050106676 Novel proteins having hemolytic activity and genes encoding the protein |
| 05/19/2005 | US20050106675 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/19/2005 | US20050106674 Ephrin receptor binding protein for use as tool in treatment and prevention of cell proliferative and nervous system disorders |
| 05/19/2005 | US20050106672 Neurotransmission associated proteins |
| 05/19/2005 | US20050106670 Isolated human G-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human GPCR proteins, and uses thereof |
| 05/19/2005 | US20050106659 Membrane protein for use as tool in detection of modulators for diagnosis, prevention and treatment of neurological and/or psychiatric diseases |
| 05/19/2005 | US20050106641 Using reporter gene expression to identify cells exhibiting preferential immunoglobulin secretory profiles; utilizing submicron sized particulate labels containing signal-generating moieties whose hue can be adjusted over range of distinguishable types, as reporter tools in multiplex analysis |
| 05/19/2005 | US20050106636 Method and kit for detecting membrane protein-protein interactions |
| 05/19/2005 | US20050106634 Using L1 cell adhesion protein as tool in neurons, neural and/or neuronal progenitor cells for use in treatment of nervous system disorders |
| 05/19/2005 | US20050106614 Reagents and methods useful for detecting diseases of the prostate |
| 05/19/2005 | US20050106601 Transgenic mouse whose somatic and germ cells express an Fkhsf transgene and mutants; immunomodulators |
| 05/19/2005 | US20050106599 Nucleotide sequences coding secretfed protein for use as tools in generating antibodies for use in forensics, gene therapeutics and diagnostics and chromosome mapping |
| 05/19/2005 | US20050106595 Expressed sequence tags and encoded human proteins |
| 05/19/2005 | US20050106582 Transgenic cells comprising expression vectors coding transcription factors for use as tool in identifying modulators for prevention and treatment of cell proliferative, metabolic and immune disorders |
| 05/19/2005 | US20050106581 Phosphodiesterase polypeptides for use in identifying modulators for prevention and treatment of inflammatory disease |
| 05/19/2005 | US20050106567 Nucleotide sequences coding tau protein for use as diagnostic tool in detection of alzheimer's and neurodegenerative disorders |
| 05/19/2005 | US20050106558 Generating viral expression vector comprising parvoviral structural genes for use as gene transfer and expression tool; treatment and prevention of infections, cell proliferative and autoimmune disorders |
| 05/19/2005 | US20050106554 Cryopreservation of pluripotent stem cells |
| 05/19/2005 | US20050106553 Rendering material suitable for storage via spraying into hot gas stream an aqueous mixture and carrier, drying mixture to particles , separating partiles from gas stream; storage of materials by incorporating them into water-soluble or water-swellable substance |
| 05/19/2005 | US20050106222 Genetic engineering; gene expression; polypeptides |
| 05/19/2005 | US20050106154 GASP1: a follistatin domain containing protein |
| 05/19/2005 | US20050106149 Antibodies abolish prion propagation and remote clearance of infectivity |
| 05/19/2005 | US20050106145 Anti-human tenascin monoclonal antibody |
| 05/19/2005 | US20050106140 Antagonistic anti-hfas ligand human antibodies and fragments thereof |
| 05/19/2005 | US20050106129 Method of obtaining immune cells from an animal |
| 05/19/2005 | US20050106127 Graft to humans; culture product; removing cells; preservation |
| 05/19/2005 | US20050106099 Fusion proteins |
| 05/19/2005 | DE19905501B4 Verfahren zur Herstellung eines rekombinanten Adeno-assoziierten Virus, geeignete Mittel hierzu sowie Verwendung zur Herstellung eines Arzneimittels A method of producing a recombinant adeno-associated virus, as well as suitable means to this end use for the preparation of a medicament |
| 05/19/2005 | DE10347436A1 In vitro Verfahren zur Diagnose der kardiovaskulären Funktionalität von Knochenmarks-Vorläuferzellen (BMP) und/oder Blut-abgeleiteter zirkulierender Vorläuferzellen (BDP) An in vitro method for diagnosing the cardiovascular functionality of bone marrow precursor cells (BMP) and / or blood-derived circulating precursor cells (BDP) |
| 05/19/2005 | DE102004025081A1 Preparation of three-dimensional tissue and organ cultures, useful as implants or for producing tissue or organ-specific substances, comprises use of cell aggregates generated from adult stem cells |
| 05/19/2005 | CA2544949A1 Antagonist anti-cd40 monoclonal antibodies and methods for their use |
| 05/19/2005 | CA2544821A1 Simian orl1 gene and method of assessing compound |
| 05/19/2005 | CA2544807A1 Compositions and methods of using apoptosis signaling kinase related kinase (askrk) |
| 05/19/2005 | CA2544214A1 Hla-dr-binding antigen peptide derived from wt1 |
| 05/19/2005 | CA2543977A1 Use of particulate labels in bioanalyte detection methods |
| 05/19/2005 | CA2543917A1 Use of a hydrogel for the culture of chondrocytes |
| 05/19/2005 | CA2543013A1 Rna interference mediated inhibition of nogo and nogo receptor gene expression using short interfering nucleic acid (sina) |
| 05/19/2005 | CA2542835A1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 05/19/2005 | CA2537759A1 Monomeric recombinant mhc molecules useful for manipulation of antigen-specific t cells |
| 05/19/2005 | CA2535147A1 Improved glucose dehydrogenase polypeptides and related polynucleotides |
| 05/19/2005 | CA2528574A1 Genes encoding carotenoid compounds |
| 05/18/2005 | EP1530970A1 Composition and method for inducing immune tolerance towards cell, tissue and/or organ transplants |
| 05/18/2005 | EP1530648A1 Methods and device for decarbonising a steel melt |
| 05/18/2005 | EP1530637A2 Subtilisin carlsberg proteins with reduced immunogenicity |
| 05/18/2005 | EP1530632A2 Growth factor which acts through erb b-4 rtk |
| 05/18/2005 | EP1530631A2 Multiply-substituted protease variants |
| 05/18/2005 | EP1530630A2 Novel lipases and uses thereof |
| 05/18/2005 | EP1530628A1 Process for the production of temperature-induced tumor cell lysates for use as immunogenic compounds |
| 05/18/2005 | EP1530586A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 05/18/2005 | EP1530418A2 Methods of identifying and isolating stem cells and cancer stem cells |
| 05/18/2005 | EP1472358A4 Non-linear amplitude dielectrophoresis waveform for cell fusion |
| 05/18/2005 | EP1436381B1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 05/18/2005 | EP1246908B1 Cod uracil-dna glycosylase, gene coding therefore, recombinant dna containing said gene or operative parts thereof, a method for preparing said protein and the use of said protein or said operative parts thereof in monitoring or controlling pcr |
| 05/18/2005 | EP1212442B1 Enhanced plant cell transformation by addition of host genes involved in t-dna integration |
| 05/18/2005 | EP1161530B1 Protein for blocking platelet adhesion |
| 05/18/2005 | EP1145011B1 Compositions and methods for the diagnosis and treatment of tumor |
| 05/18/2005 | EP1034185B1 Pharmaceutical compositions containing the long pentraxin ptx3 |
| 05/18/2005 | EP0970187B1 Pituitary differentiation factor and methods of use thereof |
| 05/18/2005 | EP0942999B1 Gene trap construct for identification and isolation of genes |
| 05/18/2005 | EP0894141B1 Hybrid proteins which form heterodimers |
| 05/18/2005 | EP0839055B1 Modified methioninase, its use, recombinant host cells producing high levels of methioninase and method for purifying methioninase |
| 05/18/2005 | EP0839044B1 Dendritic-like cell/tumor cell hybrids for inducing an anti-tumor response |
| 05/18/2005 | EP0719342B1 Processes for producing polyhydroxybutyrate and related polyhydroxyalkanoates in the plastids of higher plants |
| 05/18/2005 | EP0662137B1 Gene transcription and ionizing radiation: methods and compositions |
| 05/18/2005 | EP0595896B1 Transgenic plants producing polyhydroxyalkanoates |
| 05/18/2005 | CN1618018A Process for the measurement of the potency of glatiramer acetate |
| 05/18/2005 | CN1617932A Degradation of hydrophobic esters pesticide and toxins |
| 05/18/2005 | CN1617926A A structure for presenting desired peptide sequences |
| 05/18/2005 | CN1617924A Method for large scale production of virus antigen |
| 05/18/2005 | CN1617923A Method of large scale production of hepatitis a virus |
| 05/18/2005 | CN1617884A Beta-amyloid binding factors and inhibitors thereof |
| 05/18/2005 | CN1617882A Method of isolation and purification of trypsin from pronase protease and use thereof |
| 05/18/2005 | CN1617742A Methods for treating cancer by using tumor-derived dentrical cell inhibitory factor antagonist in combination with toll-like receptor agonist |
| 05/18/2005 | CN1617732A Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 05/18/2005 | CN1616671A Natural antitumor or antiviral substances and use of the same |
| 05/18/2005 | CN1616664A Transgenic plants with altered senescence characteristics |
| 05/18/2005 | CN1616661A Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
| 05/18/2005 | CN1616653A Positive monocloning method for screening transgenetic animal cell |
| 05/18/2005 | CN1202261C Methods for making recombinant cells |
| 05/18/2005 | CN1202256C Regulatory sequences useful for gene expression in plant embryo tissue |
| 05/18/2005 | CN1202255C Nucleic acid molecules which encode proteins having furctosyl transterase activity and methods for producing long-chain inulin |
| 05/18/2005 | CN1202254C Paddy rice anti bacterial leaf-blight gene Xa26(t) |
| 05/18/2005 | CN1202252C Recombination proteins of Pakistani strain of hepatitis E and their use in diagnostic method and vaccines |
| 05/18/2005 | CN1202246C Methods and means for obtaining modified phenotypes |
| 05/18/2005 | CN1202243C Human liver cancer cell line |
| 05/18/2005 | CN1202097C Benzothiadiazole compound and application in plant cell thereof |
| 05/18/2005 | CN1201825C Preparation method of artificial endometrium |
| 05/18/2005 | CN1201818C Vaccine |
| 05/17/2005 | US6894205 Assay for toxin induced neuronal degeneration and viability in C. elegans |